u/fourslider

Reddit r/investing
· tracked since Jan 2026
Calls
1
Win Rate
-
return
-
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate - Long 1 Short 0
Win Rate
7d
30d
90d
Average Return - Long Return - Short Return -
Average Return
7d
30d
90d
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 16
$5.38
-
Approved ANKTIVA and updates may drive IBRX long-term upside.
Author holds a small speculative long position and is willing to hold for 1-2 years if a real runway develops. He notes IBRX now has a marketed product (ANKTIVA) in bladder cancer and additional regulatory/clinical updates, which he sees as potential durable inflection points rather than pure pipeline speculation. His main concern is that the recent +35% move may be sentiment-driven and ahead of fundamentals.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

u/fourslider has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology